Cargando…

Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides

The prebiotic potential of fructo-oligosaccharides (microbial-FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non-microbial commercial FOS sample. Prebiotics were f...

Descripción completa

Detalles Bibliográficos
Autores principales: Roupar, Dalila, Coelho, Marta C., Gonçalves, Daniela A., Silva, Soraia P., Coelho, Elisabete, Silva, Sara, Coimbra, Manuel A., Pintado, Manuela, Teixeira, José A., Nobre, Clarisse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997964/
https://www.ncbi.nlm.nih.gov/pubmed/35407041
http://dx.doi.org/10.3390/foods11070954
_version_ 1784684829314383872
author Roupar, Dalila
Coelho, Marta C.
Gonçalves, Daniela A.
Silva, Soraia P.
Coelho, Elisabete
Silva, Sara
Coimbra, Manuel A.
Pintado, Manuela
Teixeira, José A.
Nobre, Clarisse
author_facet Roupar, Dalila
Coelho, Marta C.
Gonçalves, Daniela A.
Silva, Soraia P.
Coelho, Elisabete
Silva, Sara
Coimbra, Manuel A.
Pintado, Manuela
Teixeira, José A.
Nobre, Clarisse
author_sort Roupar, Dalila
collection PubMed
description The prebiotic potential of fructo-oligosaccharides (microbial-FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non-microbial commercial FOS sample. Prebiotics were fermented in vitro by fecal microbiota of five healthy volunteers. Microbial-FOS significantly stimulated the growth of Bifidobacterium probiotic strains, triggering a beneficial effect on gut microbiota composition. A higher amount of total short-chain fatty acids (SCFA) was produced by microbial-FOS fermentation as compared to commercial-FOS, particularly propionate and butyrate. Inulin neoseries oligosaccharides, with a degree of polymerization (DP) up to 5 (e.g., neokestose and neonystose), were identified only in the microbial-FOS mixture. More than 10% of the microbial-oligosaccharides showed a DP higher than 5. Differences identified in the structures of the FOS samples may explain their different functionalities. Results indicate that microbial-FOS exhibit promising potential as nutraceutical ingredients for positive gut microbiota modulation.
format Online
Article
Text
id pubmed-8997964
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89979642022-04-12 Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides Roupar, Dalila Coelho, Marta C. Gonçalves, Daniela A. Silva, Soraia P. Coelho, Elisabete Silva, Sara Coimbra, Manuel A. Pintado, Manuela Teixeira, José A. Nobre, Clarisse Foods Article The prebiotic potential of fructo-oligosaccharides (microbial-FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non-microbial commercial FOS sample. Prebiotics were fermented in vitro by fecal microbiota of five healthy volunteers. Microbial-FOS significantly stimulated the growth of Bifidobacterium probiotic strains, triggering a beneficial effect on gut microbiota composition. A higher amount of total short-chain fatty acids (SCFA) was produced by microbial-FOS fermentation as compared to commercial-FOS, particularly propionate and butyrate. Inulin neoseries oligosaccharides, with a degree of polymerization (DP) up to 5 (e.g., neokestose and neonystose), were identified only in the microbial-FOS mixture. More than 10% of the microbial-oligosaccharides showed a DP higher than 5. Differences identified in the structures of the FOS samples may explain their different functionalities. Results indicate that microbial-FOS exhibit promising potential as nutraceutical ingredients for positive gut microbiota modulation. MDPI 2022-03-25 /pmc/articles/PMC8997964/ /pubmed/35407041 http://dx.doi.org/10.3390/foods11070954 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Roupar, Dalila
Coelho, Marta C.
Gonçalves, Daniela A.
Silva, Soraia P.
Coelho, Elisabete
Silva, Sara
Coimbra, Manuel A.
Pintado, Manuela
Teixeira, José A.
Nobre, Clarisse
Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides
title Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides
title_full Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides
title_fullStr Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides
title_full_unstemmed Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides
title_short Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides
title_sort evaluation of microbial-fructo-oligosaccharides metabolism by human gut microbiota fermentation as compared to commercial inulin-derived oligosaccharides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997964/
https://www.ncbi.nlm.nih.gov/pubmed/35407041
http://dx.doi.org/10.3390/foods11070954
work_keys_str_mv AT roupardalila evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT coelhomartac evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT goncalvesdanielaa evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT silvasoraiap evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT coelhoelisabete evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT silvasara evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT coimbramanuela evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT pintadomanuela evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT teixeirajosea evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides
AT nobreclarisse evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides